| Monkeypox virus infection in humans across 16 countries—April–June 2022 JP Thornhill, S Barkati, S Walmsley, J Rockstroh, A Antinori, LB Harrison, ... New England Journal of Medicine 387 (8), 679-691, 2022 | 1691 | 2022 |
| COVID-19 in patients with HIV: clinical case series JL Blanco, J Ambrosioni, F Garcia, E Martínez, A Soriano, J Mallolas, ... The lancet. HIV 7 (5), e314, 2020 | 508 | 2020 |
| Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022 A Peiró-Mestres, I Fuertes, D Camprubí-Ferrer, MÁ Marcos, A Vilella, ... Eurosurveillance 27 (28), 2200503, 2022 | 337 | 2022 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 282 | 2015 |
| HIV-1 integrase inhibitor resistance and its clinical implications JL Blanco, V Varghese, SY Rhee, JM Gatell, RW Shafer Journal of Infectious Diseases 203 (9), 1204-1214, 2011 | 279 | 2011 |
| Mpox in people with advanced HIV infection: a global case series O Mitjà, A Alemany, M Marks, JIL Mora, JC Rodríguez-Aldama, MST Silva, ... The Lancet 401 (10380), 939-949, 2023 | 237 | 2023 |
| Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series JP Thornhill, R Palich, J Ghosn, S Walmsley, D Moschese, CP Cortes, ... The Lancet 400 (10367), 1953-1965, 2022 | 106 | 2022 |
| Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial JL Blanco, J Rojas, R Paredes, E Negredo, J Mallolas, M Casadella, ... Journal of Antimicrobial Chemotherapy 73 (7), 1965-1971, 2018 | 76 | 2018 |
| Dolutegravir resistance mutations: lessons from monotherapy studies JL Blanco, AG Marcelin, C Katlama, E Martinez Current opinion in infectious diseases 31 (3), 237-245, 2018 | 51 | 2018 |
| Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM … J Rojas, E de Lazzari, E Negredo, P Domingo, J Tiraboschi, E Ribera, ... The Lancet HIV 8 (8), e463-e473, 2021 | 20 | 2021 |
| HIV DNA sequencing to detect archived antiretroviral drug resistance AM Geretti, JL Blanco, AG Marcelin, CF Perno, HJ Stellbrink, D Turner, ... Infectious Diseases and Therapy 11 (5), 1793-1803, 2022 | 19 | 2022 |
| A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity J Rojas, JL Blanco, S Sanchez-Palomino, MA Marcos, AC Guardo, ... Aids 32 (12), 1633-1641, 2018 | 11 | 2018 |
| Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV: a single-center, prospective observational study A Inciarte, A Gonzalez-Cordon, J Rojas, B Torres, E de Lazzari, ... Aids, 2020 | 10 | 2020 |
| A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine E de Lazzari, M Lonca, J Rojas, A Gonzalez-Cordon, J Blanch, A Inciarte, ... Aids 33 (12), 1891-1896, 2019 | 10 | 2019 |
| Effective Treatment of Lymphogranuloma venereum Proctitis With Azithromycin JL Blanco, I Fuertes, J Bosch, E De Lazzari, A Gonzalez-Cordón, ... Clinical Infectious Diseases 73 (4), 614-620, 2021 | 8 | 2021 |
| Treatment and prevention of monkeypox F de la Calle-Prieto, ME Muñoz, G Ramírez, M Díaz-Menéndez, ... Enfermedades infecciosas y microbiologia clinica (English ed.) 41 (10), 629-634, 2023 | 7 | 2023 |
| The effectiveness and tolerability of imiquimod suppositories to treat extensive intra-anal high-grade squamous intraepithelial lesions/warts in HIV-infected individuals I Fuertes, C Bastida, C Lopez-Cabezas, L Rodríguez-Carunchio, J Ordi, ... International journal of STD & AIDS 30 (12), 1194-1200, 2019 | 7 | 2019 |
| Characteristics and management of ocular involvement in individuals with monkeypox disease M Pazos, J Riera, A Moll-Udina, A Catala, S Narvaez, I Fuertes, ... Ophthalmology 130 (6), 655-658, 2023 | 4 | 2023 |
| Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy P Vizcarra, JL Blanco, R Montejano, E Negredo, N Espinosa, JL Casado, ... Infectious Diseases 52 (3), 202-206, 2020 | 3 | 2020 |
| Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study A Martínez-Serra, E De Lazzari, L Berrocal, A Foncillas, L De La Mora, ... Journal of Antimicrobial Chemotherapy 78 (8), 1955-1962, 2023 | 2 | 2023 |
